Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-057651
Filing Date
2014-09-12
Accepted
2014-09-12 13:09:56
Documents
1
Period of Report
2014-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3858
  Complete submission text file 0001209191-14-057651.txt   5164
Mailing Address 435 DEVON PARK BUILDING 800 WAYNE PA 19087-1945
Business Address
COLA MICHAEL F (Reporting) CIK: 0001188940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 141100233

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations